An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.
This study has been completed.
Sponsor:
SK Life Science
Information provided by (Responsible Party):
SK Life Science
ClinicalTrials.gov Identifier:
NCT00991757
First received: October 6, 2009
Last updated: January 15, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2010 |
| Primary Completion Date: | October 2010 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | January 15, 2013 |